Bio-IT World News
YouTube Facebook LinkedIn TwitterInstagram rss
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • View Press Releases
    • Post a Press Release
    • Reprint Articles
  • Podcast
  • Advertise
    • Media Kit
    • Digital Advertising
    • Lead Generation
    • Editorial Calendar
    • Webinars
    • Whitepapers
    • Podcasts
    • View Press Releases
    • Post a Press Release
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Webinars
    • Inside eBooks
  • Events
    • Webinars
    • Industry Events
    • IT Conferences
    • Bio-IT World Expo
    • Bio-IT World Expo Europe
  • About Us
    • Editorial Profile
    • Editorial Calender
    • Contact Us
    • Submit a story
    • Innovative Practices Awards
    • Linking Policy
  • Bio-IT World Expo
    • Bio-IT World Boston
    • Bio-IT World Europe
 
 
 
 
  • Medidata and PPD Partner to Offer New Approach to Risk-Based Monitoring

    Nov 4, 2014, 00:00 AM by Michael Croft
    NEW YORK, NY - Nov 4, 2014 - Medidata (NASDAQ: MDSO), a leading global provider of cloud-based solutions for clinical research in life sciences, and Pharmaceutical Product Development, LLC (PPD), a global contract research organization (CRO), today announced they are expanding their partnership to provide the life science industry with a more comprehensive approach to risk-based monitoring (RBM)—aimed at conducting drug development more intelligently, more quickly and more cost-effectively
    Full story
  • SRA Joins the Global Alliance for Genomics and Health

    Nov 4, 2014, 00:00 AM by Michael Croft
    NEW YORK, NY - Nov 4, 2014 -  SRA International, Inc., a leading provider of IT solutions and professional services to government organizations, announced that it has joined the Global Alliance for Genomics and Health (Global Alliance) as an Organizational Member
    Full story
  • NCI Awards Contracts for Cancer Genomics Cloud Pilots

    Nov 3, 2014, 14:00 PM by Michael Croft
    Bio-IT World News Brief | The National Cancer Institute has chosen two academic institutes and one private company to develop separate compute infrastructures for the analysis of cloud-hosted genomics data generated by large, public projects.
    Full story
  • Jonathan Rothberg Pursues Mobile Ultrasound

    Nov 3, 2014, 11:20 AM by Michael Croft
    MIT Technology Review | Jonathan Rothberg, founder of both 454 Life Sciences and Ion Torrent, is touting a new startup from his 4Combinator tech incubator that is developing a low-cost ultrasound device to plug into a smartphone.
    Full story
  • RainDance Technologies Appoints Martin M. Coyne II and Glenn P. Muir to Board of Directors

    Nov 3, 2014, 00:00 AM by Michael Croft
    BILLERICA, MA - Nov 3, 2014 - RainDance Technologies, Inc., a genomics tools company simplifying the analysis of complex genetic diseases, today announced the appointment of Martin M
    Full story
  • A Brief Introduction of Creative Animodel’s Bioanalysis

    Nov 3, 2014, 00:00 AM by Michael Croft
    SHIRLEY, NY - Nov 3, 2014 - Bioanalytical services help scientists to get more scientific findings. The professional team of Creative Animodel provides creative bioanalysis services, assuring the quality and cost of its services and products
    Full story
  • A Brief Introduction of Creative Animodel’s Bioanalysis(2)

    Nov 3, 2014, 00:00 AM by Michael Croft
    SHIRLEY, NY - Nov 3, 2014 - Bioanalytical services help scientists to get more scientific findings. The professional team of Creative Animodel provides creative bioanalysis services, assuring the quality and cost of its services and products
    Full story
  • Certara Updates Its Industry-Leading PK/PD Phoenix Platform and Introduces Phoenix Quantum Packages for Enhanced Collaboration and Efficiency

    Nov 3, 2014, 00:00 AM by Michael Croft
    PRINCETON, NJ - Nov 3, 2014 - Certara®, the leading global technology-enabled drug development and drug safety consultancy, today announced the launch of version 1
    Full story
  • In a Restless Preclinical Testing Market, Organs-on-Chips Company MIMETAS Is in Expansion Mode

    Oct 31, 2014, 09:30 AM by Michael Croft
    Bio-IT World | Dutch startup MIMETAS, whose microfluidics technology forms a platform for three-dimensional, multi-cell-type tissue cultures, is securing new funding and partnerships as it expands its line of drug screening models.
    Full story
  • Medidata Selected by ASLAN Pharmaceuticals as Enterprise-Wide Technology Platform for Enhancing Clinical Development

    Oct 30, 2014, 00:00 AM by Michael Croft
    NEW YORK, NY - Oct 30, 2014 - Medidata (NASDAQ: MDSO), the leading global provider of cloud-based solutions for clinical research in life sciences, today announced that it has signed an enterprise agreement with ASLAN Pharmaceuticals, an oncology-focused biotechnology company
    Full story
  • Expanding the Search for Knockout Mutations to the Human Population

    Oct 29, 2014, 08:40 AM by Michael Croft
    Nature News | With mass sequencing of humans now a practical reality, several large population studies are searching for people with rare mutations that completely knock out specific genes, to uncover these genes' functions and potentially new drug targets.
    Full story
  • KCR Eliminates the Burden of Paper with Cloud-Based Content Management Solution

    Oct 28, 2014, 00:00 AM by Michael Croft
    WARSAW, POLAND - Oct 28, 2014 - KCR, a European Contract Research Organization (CRO) operating across 19 European countries and in the US, has turned to the cloud in a move to improve cross-functional collaboration and trial operations
    Full story
  • Personalized medicine: Genomics helps BC pharmacists target the right drugs for the right patient

    Oct 28, 2014, 00:00 AM by Michael Croft
    VANCOUVER, BC, CANADA - Oct 28, 2014 - An exciting new research project that aims to make personalized medicine a reality for patients is launching in a number of community pharmacies across British Columbia
    Full story
  • Large Funding Round for Massachusetts Biotech Syros

    Oct 27, 2014, 08:45 AM by Michael Croft
    Xconomy | Syros Pharmaceuticals, a biotech focused on creating drugs that target gene expression regulatory pathways, has announced a $53 million Series B financing round.
    Full story
  • Dow Chemical Licenses Simulations Plus Software to Assist with Toxicology and Environmental Research

    Oct 27, 2014, 00:00 AM by Michael Croft
    LANCASTER, CA - Oct 27, 2014 - Simulations Plus, Inc. (NASDAQ: SLP), a leading provider of software for discovery and development, announced that The Dow Chemical Company (NYSE: DOW) has licensed both its best-in-class Full story
  • Whole Genome Resequencing: Using the Known to Find the Unknown

    Oct 26, 2014, 00:00 AM by Michael Croft
    SHIRLEY, NY - Oct 26, 2014 - Whole genome resequencing is a laboratory process that determines the complete DNA sequence of an organism's genome which is already known
    Full story
  • The Peculiar Internet Market for Genetic Health Reports

    Oct 24, 2014, 13:25 PM by Michael Croft
    MIT Technology Review | Since the FDA made clear last November that it would not tolerate companies selling genetic tests linked to health reports without regulatory approval, a workaround for customers of companies like 23andMe has emerged online.
    Full story
  • New Microscopy Technique Offers Astounding Resolution Over Time

    Oct 23, 2014, 14:15 PM by Michael Croft
    Bio-IT World News Brief | A paper published today in Science describes a new type of fluorescence microscope that is capable of taking images of living, three-dimensional systems over long periods of time without degrading cells or fluorescent molecules.
    Full story
  • Certara Receives FDA Grant to Enhance Simcyp Simulator’s Mechanistic Dermal Absorption Model to Permit Drug Bioequivalence Assessment

    Oct 23, 2014, 00:00 AM by Michael Croft
    ST. LOUIS, MO - Oct 23, 2014 - Certara®, the leading global technology-enabled drug development and drug safety consultancy, today announced that it has received a Food and Drug Administration (FDA) Office of Generic Drugs grant (#1 U01 FD005225-01) to further develop and validate its Simcyp® Simulator’s mechanistic dermal absorption model, MechDermA
    Full story
  • Certara Receives FDA Grant to Enhance Simcyp Simulator’s Mechanistic Dermal Absorption Model to Permit Drug Bioequivalence Assessment(2)

    Oct 23, 2014, 00:00 AM by Michael Croft
    ST. LOUIS, MO - Oct 23, 2014 - Certara®, the leading global technology-enabled drug development and drug safety consultancy, today announced that it has received a Food and Drug Administration (FDA) Office of Generic Drugs grant (#1 U01 FD005225-01) to further develop and validate its Simcyp® Simulator’s mechanistic dermal absorption model, MechDermA
    Full story
  • «
  • 381
  • 382
  • 383
  • 384
  • 385
  • 386
  • 387
  • 388
  • 389
  • 390 (current)
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

Barnett Educational Services

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy